David L. Luterman, M.D.
NPI 1629079751ActiveIndividual· Internal Medicine, Pulmonary Disease· Dallas, TX
Internal Medicine, Pulmonary Disease (M.D.) in Dallas, Texas, trained at University of Texas Southwestern Medical School at Dallas (class of 1970). Their prescriptions cost Medicare Part D more than their services did: $1,449,220 for 2,134 claims, against $138,915 paid for services in 2024. Glaxosmithkline, LLC. was the largest of 14 companies reporting payments in 2025, $1,369 in all, mostly food and beverage.
Overview
| NPI | 1629079751 |
|---|---|
| Status | Active |
| Entity type | Individual |
| Credential | M.D. |
| Sole proprietor | No |
| NPI issued | Aug 10, 2005 |
| Last updated in NPPES | Jul 6, 2025 |
| Certified by provider | Jul 6, 2025 |
Specialties and licenses
| Taxonomy | Code | License | State |
|---|---|---|---|
| Internal Medicine, Pulmonary Disease Primary | 207RP1001X | D7162 | TX |
| Internal Medicine, Sleep Medicine | 207RS0012X | D7162 | TX |
Exclusion screening
| List | Result | Details |
|---|---|---|
| HHS-OIG LEIE · Nov 10, 2026 | No match | Checked by NPI and by name + state |
| North Carolina Medicaid · Nov 11, 2026 | No match | — |
| New York OMIG · Nov 11, 2026 | No match | — |
| Ohio Medicaid · Nov 11, 2026 | No match | — |
| Pennsylvania Medicheck · Nov 11, 2026 | No match | — |
| Washington HCA · Nov 11, 2026 | No match | — |
Official OIG search · How matching works ·Bulk check a roster
Medicare
| Enrollment (PECOS) | Enrolled Practitioner - Pulmonary Disease (TX) |
|---|---|
| Accepts assignment | Yes (participating) |
Medicare services in 2024
| Medicare patients | 623 |
|---|---|
| Services billed | 2,218 across 27 procedure codes |
| Paid by Medicare | $138,915 |
Part D prescriptions in 2024
| Prescriptions (claims) | 2,134 · 3,721 30-day fills |
|---|---|
| Patients | 338 |
| Total drug cost | $1,449,220 |
| Generic share | 54% of claims |
Education and affiliations
| Medical school | University of Texas Southwestern Medical School at Dallas |
|---|---|
| Graduation year | 1970 |
| Medicare specialty | Pulmonary Disease |
| Secondary specialties | Critical Care (Intensivists) |
Hospital affiliation
Industry payments (Open Payments)
- 2025$1,369 · 69 payments from 14 companies
- 2024$1,272 · 78 payments from 15 companies
Top paying companies in 2025
| Company | Amount | Payments |
|---|---|---|
| Glaxosmithkline, LLC. | $319.95 | 20 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $299.56 | 6 |
| Astrazeneca Pharmaceuticals LP | $277.80 | 23 |
| Insmed, Inc. | $113.44 | 5 |
| Viatris Specialty LLC | $69.78 | 3 |
What the 2025 payments were for
- Food and Beverage$1,335 · 68 payments
- Education$34.00 · 1 payment
Receiving payments does not imply wrongdoing. What Open Payments covers ·original records
Other pulmonologists in Dallas
- 1013093293
- 1023436151
- 1063701605
- 1104916782
- 1124071956
- 1164468450
- 1174934004
- 1184714768
- 1184836355
- 1205218369
- 1205275336
- 1205856366
All 159 pulmonologists in Dallas · All pulmonologists in Texas